Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
276 hedge funds and large institutions have $5.28B invested in Athenahealth, Inc. in 2018 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 98 increasing their positions, 69 reducing their positions, and 56 closing their positions.
49% more call options, than puts
Call options by funds: $222M | Put options by funds: $149M
42% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 69
4% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 56
0% more funds holding
Funds holding: 275 → 276 (+1)
20% less capital invested
Capital invested by funds: $6.63B → $5.28B (-$1.35B)
78% less funds holding in top 10
Funds holding in top 10: 9 → 2 (-7)
Top Buyers
Top Sellers
ATHN Hedge Fund Activity: Q3 2018 in Review
276 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q3 2018, worth a combined $5.28B — down 20% from $6.63B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new ATHN positions and 56 closed out — a net gain of 2 holders — while 98 added to existing stakes and 69 trimmed.
The largest buyer was Jupiter Investment Management, opening a new position worth an estimated $119M. The largest seller was T. Rowe Price Associates, cutting an estimated $219M.
- 276 institutional investors held Athenahealth, Inc. (ATHN) as of Q3 2018, up from 275 in Q2 2018.
- Funds reported $5.28B of Athenahealth, Inc. stock for Q3 2018, down 20% quarter-over-quarter.
- 58 funds opened new Athenahealth, Inc. positions in Q3 2018 and 56 closed out, a net change of +2 holders.
- The largest Athenahealth, Inc. buyer in Q3 2018 was Jupiter Investment Management, an estimated $119M added.
- The largest Athenahealth, Inc. seller in Q3 2018 was T. Rowe Price Associates, an estimated $219M sold.
Based on aggregated 13F filings for Q3 2018.